Close Menu

NEW YORK (GenomeWeb) – The US Patent and Trademark Office has denied an attempt by Foundation Medicine to invalidate a patent held by Guardant Health.

In a decision issued June 5, the Patent Trial and Appeal Board denied Foundation Medicine's request to institute Inter Partes review for US Patent No. 9,598,731.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
25

This webinar will discuss the evolution of fetal aneuploidy screening and the most recent evidence around the implementation of prenatal cell-free DNA testing in clinical practice.

Jul
31
Sponsored by
Thermo Fisher Scientific

This webinar will provide a first-hand look at how a molecular laboratory validated and implemented a targeted next-generation sequencing-based myeloid assay to expedite the assessment of myeloid malignancies and assist in the understanding of myeloid cancers.